Interleukin-2 soon may receive FDA's green light.
Marwick
C
C
D006801:Humans; D007376:Interleukin-2; D007680:Kidney Neoplasms / Q000628:therapy; D014481:United States; D014486:United States Food and Drug Administration
D007376:Interleukin-2